No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

XIMEPEG, poudre pour solution buvable | Pharmacountry

Products
Finished Dosage Forms
Powders
Powders for Oral Suspension/Solution

XIMEPEG, poudre pour solution buvable

AF

ALFASIGMA FRANCE

Marketing Authorization Holder · Finished Dosage FormsFrance

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Powders / Powders for Oral Suspension/Solution

Trade Type

Sell

Product Name

XIMEPEG, poudre pour solution buvable

Details

SULFATE DE SODIUM ANHYDRE 3,75 g • MACROGOL 4000 52,5 g • SIMÉTICONE 0,08 g • ACIDE CITRIQUE ANHYDRE 0,813 mg • CHLORURE DE POTASSIUM 0,37 g • CHLORURE DE SODIUM 0,73 mg • CITRATE DE SODIUM 1,863 g

Substance

SULFATE DE SODIUM ANHYDRE • Macrogol 4000 • SIMÉTICONE • ACIDE CITRIQUE ANHYDRE • CHLORURE DE POTASSIUM • CHLORURE DE SODIUM • CITRATE DE SODIUM

Registered Market

France

Specifications

Dosage Form: Powder for oral solution
Packaging: 1 traitement contenant 4 grands sachets A (paper/polyethylene/aluminum) + 4 petits sachets B (paper/polyethylene/aluminum)

Documents

Drug Marketing Authorization Number

Document No.: 62090079

Issue Date: Apr 21, 2017